| 前收市價 | 0.0500 |
| 開市 | 0.0500 |
| 買盤 | 0.0000 |
| 賣出價 | 0.0500 |
| 拍板 | 2.50 |
| 到期日 | 2024-07-19 |
| 今日波幅 | 0.0500 - 0.0500 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 421 |
ZacksMicrobot Medical (MBOT) Files IDE to Start Human Clinical Study
Microbot Medical (MBOT) files an IDE with the FDA, approval of which will enable the company to proceed with its human clinical study in the United States.
InvestorPlace3 Stocks at the Forefront of Medical Robotics
Every now and then, speculation – within carefully defined limits – may be appropriate, which brings us to the case for medical robotics stocks to buy. Sure, you can gamble on just about anything these days and a non-zero probability exists for their upside. During the post-pandemic period, we’ve seen everything from video game retailers to private prisons skyrocket via pure hypothesizing in action. However, medical robotics stocks offer a genuinely viable (albeit risky) path to significant mark
